Skip to content

Functional cure strategy and clinical study of AIDS-Effects of probiotics on regulating intestinal microecology and HIV reservoir in HIV patients

Functional cure strategy and clinical study of AIDS-Effects of probiotics on regulating intestinal microecology and HIV reservoir in HIV patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077736
Enrollment
Unknown
Registered
2023-11-17
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Immune Deficiency Syndrome

Interventions

probiotics+ART:probiotics+ART
ART:ART

Sponsors

The First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1: Age was 18 (inclusive) -65 years old 2: HIV infection was confirmed by primary screening test and Western Blot confirmatory test 3: ART therapy were used for 1 year or more, and integrase inhibitor-based ART therapy regimens were used for the last 3 months 4: HIV viral load was less than 20copies/ml 5: CD4+T cells count was greater than or equal to 200 /mm3 and less than 500 /mm3 6: Informed consent was voluntarily signed, and regular follow-up and specimen collection and related treatment adverse reactions were guaranteed 7: Contraceptives were used from 4 weeks before the study to 4 weeks after the study

Exclusion criteria

Exclusion criteria: 1: Pregnant or lactating women, or planned pregnancy during the study observation period 2: Poor treatment compliance 3: under serious cardiovascular, respiratory, kidney, liver, brain or other basic diseases 4: Suffering from serious mental illness 5: Having a malignant tumor 6: suffering from active opportunistic infections 7: Allergic to study drugs or other contraindications to treatment 8: Unwilling to sign patient informed consent 9: Other conditions were not considered appropriate for inclusion in the study

Design outcomes

Primary

MeasureTime frame
Bifidobacterium/Enterobacterium ratio;

Secondary

MeasureTime frame
Peripheral blood HIV reservoir;sCD14;T cell subgroup;

Countries

China

Contacts

Public ContactYimin Zhang

The First Affiliated Hospital, College of Medicine, Zhejiang University

1307020@zju.edu.cn+86 135 8818 0966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026